ERIS Lifesciences Ltd Quarterly Results

Gross Sales

702.6

722.12

738.95

715.59

547.27

Excise Duty

0

0

0

0

0

Net Sales

702.6

722.12

738.95

715.59

547.27

Other Operating Income

2.7

5.33

2.22

4.13

3.66

Other Income

8.01

4.22

4.55

1.64

15.15

Total Income

713.31

731.67

745.72

721.36

566.08

Total Expenditure

452.91

477.14

476.66

469.73

402.5

PBIDT

260.4

254.53

269.06

251.63

163.58

Interest

54.28

57.17

59.47

60.37

33.03

PBDT

206.12

197.36

209.59

191.26

130.55

Depreciation

77.25

81

80.48

75.94

53.8

Minority Interest Before NP

0

0

0

0

0

Tax

31.39

24.86

30.25

25.34

15.73

Deferred Tax

-4.87

4.44

2.51

0.56

-18.68

Reported Profit After Tax

102.35

87.06

96.35

89.42

79.7

Minority Interest After NP

8.51

3.3

4.76

6.24

8.67

Net Profit after Minority Interest

93.84

83.76

91.59

83.18

71.03

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

93.84

83.76

91.59

83.18

71.03

EPS (Unit Curr.)

6.9

6.16

6.73

6.11

5.22

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

735

0

0

0

Equity

13.62

13.61

13.61

13.61

13.6

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

37.06

35.24

36.41

35.16

29.89

PBDTM(%)

29.33

27.33

28.36

26.72

23.85

PATM(%)

14.56

12.05

13.03

12.49

14.56